These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 1673753)

  • 1. Ketanserin for hypertension after upper gastrointestinal surgery.
    Bogle RG
    Lancet; 1991 May; 337(8751):1219-20. PubMed ID: 1673753
    [No Abstract]   [Full Text] [Related]  

  • 2. Antihypertensive treatment with ketanserin shows no evidence of vascular serotonin2-receptor and alpha 1-adrenoceptor blockade.
    Blauw GJ; Doorenbos CJ; Bruning TA; van Brummelen P; van Zwieten PA
    Drugs; 1990; 40 Suppl 4():42-4. PubMed ID: 1982654
    [No Abstract]   [Full Text] [Related]  

  • 3. The use of ketanserin for postoperative hypertension after abdominal surgery.
    Shu CC; Chan KH; Lee TY; Lui PW; Daiy YP; Ma JY; Chow LH
    Ma Zui Xue Za Zhi; 1990 Dec; 28(4):465-70. PubMed ID: 2097488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between ketanserin and LY 53857 on vascular and cardiac 5-HT2 and alpha 1-adrenergic receptors in the pithed rat.
    Dabiré H; Chaouche-Teyara K; Cherqui C; Fournier B; Schmitt H
    Arch Int Pharmacodyn Ther; 1990; 306():57-64. PubMed ID: 1981667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The alpha-adrenergic receptor blocking effect of ketanserin and the interaction between alpha-adrenergic and S2-serotonergic receptor blockade.
    van der Starre PJ; Reneman RS
    J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S54-61. PubMed ID: 2459516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ketanserin. A new antihypertensive agent with an antagonistic effect on serotonin].
    Kristensen KS; Jensen HA; Svendsen TL
    Ugeskr Laeger; 1990 Mar; 152(12):837-8. PubMed ID: 2316048
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacological profile of antihypertensive drugs with serotonin receptor and alpha-adrenoceptor activity.
    van Zwieten PA; Blauw GJ; van Brummelen P
    Drugs; 1990; 40 Suppl 4():1-8; discussion 28-30. PubMed ID: 1982649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ketanserin for hypertension after upper gastrointestinal surgery.
    Mikulic E; Rull D; Puntoni L
    Lancet; 1991 Apr; 337(8747):976. PubMed ID: 1678053
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of alpha-adrenergic blockade in the cardiovascular actions of ketanserin: studies in patients with essential hypertension, autonomic insufficiency, and Raynaud's phenomenon.
    Brouwer RM; Wenting GJ; Man in't Veld AJ; Schalekamp MA
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S26-31. PubMed ID: 2446064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of ketanserin on glucose metabolism in hypertensive diabetic subjects].
    Carleo R; Gobbo M; Bonavita M; De Matteo A; Gallo M; Gatti A
    Boll Soc Ital Biol Sper; 1990 Jul; 66(7):639-46. PubMed ID: 1964564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihypertensive mechanism of ketanserin in postoperative hypertension after cardiopulmonary bypass.
    Anger C; Carter JA; Prys-Roberts C
    Anesth Analg; 1988 Feb; 67(2):99-106. PubMed ID: 3277483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-HT2-receptor antagonists: alpha 1- vs. 5-HT2-receptor blocking properties in blood vessels.
    Cohen ML; Schenck KW; Kurz KD
    J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S25-9. PubMed ID: 2459510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical application of serotonin antagonists in the treatment of hypertension].
    Deguchi F; Saito T; Inagaki Y
    Nihon Rinsho; 1989 Sep; 47(9):2058-63. PubMed ID: 2593279
    [No Abstract]   [Full Text] [Related]  

  • 14. [Mechanism of action and use of antagonists of serotonin receptors S2, especially ketanserin, in the treatment of various diseases of the cardiovascular system].
    Wiecek A; Grzeszczak W
    Pol Tyg Lek; 1987 Mar; 42(10):304-8. PubMed ID: 3299308
    [No Abstract]   [Full Text] [Related]  

  • 15. The acute and chronic antihypertensive effects of ketanserin cannot be explained by blockade of vascular serotonin, type 2, receptors or alpha 1-adrenergic receptors.
    Blauw GJ; van Brummelen P; Doorenbos CJ; van der Velde EA; van Zwieten PA
    Clin Pharmacol Ther; 1991 Apr; 49(4):377-84. PubMed ID: 1849810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of ketanserin in anesthesia. A selective S2 serotonin receptor antagonist].
    Nielsen LH; Knudsen F; Olesen AS
    Ugeskr Laeger; 1990 Jun; 152(23):1653-5. PubMed ID: 2194327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ketanserin in the treatment of systemic hypertension during and following coronary artery bypass surgery.
    van der Starre PJ; Reneman RS; Scheijgrond HW
    Angiology; 1989 Nov; 40(11):1001-10. PubMed ID: 2510560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of action of ketanserin in hypertension and vasospastic disease.
    Wenting GJ; Brouwer RM; vd Meiracker AJ; Man in't Veld AJ; Schalekamp MA
    Acta Cardiol; 1987; 42(5):339-54. PubMed ID: 2827406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does acute serotonergic type-2 antagonism reduce blood pressure? Comparative effects of single doses of ritanserin and ketanserin in essential hypertension.
    Hosie J; Stott DJ; Robertson JI; Ball SG
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S86-8. PubMed ID: 2446081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-adrenergic blockade makes minimal contribution to ketanserin's hypotensive effect.
    Naslund TC; Merrell WJ; Nadeau JH; Wood AJ
    Clin Pharmacol Ther; 1988 Dec; 44(6):699-703. PubMed ID: 2904312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.